Industry Experts

Venkata Indurthi, PhD, is Chief Scientific Officer of Aldevron, a Danaher Life Sciences company supporting CRISPR innovators from early research through clinical use with custom nucleases, next‑generation plasmids, RNP complexing, and analytical services. He joined Aldevron in 2016 after earning his PhD in pharmaceutical sciences from North Dakota State University and has held roles of increasing responsibility across product and process development, RNA operations, and research leadership. He earned his BS in Biotechnology from SRM University, Chennai, India.